Search alternatives:
treated decrease » greater decrease (Expand Search), greatest decrease (Expand Search), treatment decreased (Expand Search)
marked decrease » marked increase (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
sub treated » hu treated (Expand Search), b treated (Expand Search), sand treated (Expand Search)
treated decrease » greater decrease (Expand Search), greatest decrease (Expand Search), treatment decreased (Expand Search)
marked decrease » marked increase (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
sub treated » hu treated (Expand Search), b treated (Expand Search), sand treated (Expand Search)
-
1
-
2
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
3
-
4
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
5
-
6
Effects of CER on vascular calcification and phenotypic change in P<sub>i</sub><i>‐</i>treated VSMCs.
Published 2025“…Bar graphs depicted significant decrease in mRNA expression of (C) α -SMA (D) SM22α and increased (E) RUNX2 (F) OPN and (G) BMP2 in CER treated P<sub>i</sub>-induced VSMCs. …”
-
7
-
8
-
9
Effect of Gasdermin-D inhibition on CER-induced pyroptosis in P<sub>i</sub><i>‐</i>treated VSMCs.
Published 2025“…<p>Summarized bar graphs showed DIS significantly decreased mRNA expression of pyroptotic markers (A) NLRP3 (B) GSDM-D, proinflammatory cytokines (C) IL-1β (D) IL-18, and (E) Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
10
Effect of NLRP3 inhibition on CER-induced pyroptosis in P<sub>i</sub><i>‐</i>treated VSMCs.
Published 2025“…<p>Summarized bar graphs showed MCC950 significantly decreased mRNA expression of pyroptotic markers (A) NLRP3 (B) GSDM-D, proinflammatory cytokines (C) IL-1β (D) IL-18, and (E) Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20